Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Cells and Metastasis, Animal Genetics and Reproduction, Cancer-related Molecular Pathways, and Fibroblast Growth Factor Research.
Mechanisms of cancer metastasis
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis
Metastasis Organotropism: Redefining the Congenial Soil
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Genome-wide identification and differential analysis of translational initiation
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties